Honest, Open, Proud (HOP): A Peer Delivered, Co-occurring Disorders Intervention for Justice-involved Veterans (HOP)
Honest, Open, Proud (HOP) (QUE 25-014)
調査の概要
詳細な説明
Background: Justice-involved Veterans (JIVs) are highlighted as a highly vulnerable Veteran subgroup, and as many as two-thirds of JIVs have SUD, and up to 51% have a MH condition. However, fewer than one-third of JIVs receive MH or SUD treatment and addressing stigma is a recommended strategy for improving Veteran willingness to engage in treatment. Moreover, self-stigma prevents Veterans from asking for help or engaging in ongoing care. The connection between internalized self-stigma and lack of accessing care or support services impairs Veterans recovery. Interventions grounded in evidence-based, peer-led practices are effective in increasing access to and engagement in care; however, implementation of such strategies are costly and intensive. This study protocol describes a Hybrid Type III effectiveness-implementation trial of Honest, Open, Proud (HOP) with high-need, justice-involved Veterans and will evaluate the impact and cost of a high intensity (vs. low-intensity) strategy on implementation, maintenance, and sustainment outcomes.
Methods: This quality improvement (QI) project involves a Hybrid Type III implementation effectiveness trial in six VA medical centers across the United States. Sites will begin with a 6-month pre-implementation period (e.g., orientation) to examine organizational readiness to adopt VA-HOP (Aim 1). A pre-post pragmatic trial with enhancements to accommodate possible growth trends with features of an interrupted time series in which VJP staff at each site will be offered 6-months of audit and feedback (lower-intensity implementation support) followed by 6-months of implementation facilitation (higher-intensity implementation support) for promoting VA-HOP implementation by VJP staff (Aim 2). The investigators will examine whether the Veterans served by staff who delivered VA-HOP with greater model fidelity will demonstrate an increase in outpatient specialty care days, reductions in emergency department use, and reductions in suicide risk compared to Veterans who received VA-HOP with lower fidelity (Aim 3). Finally, this study will examine implementation erosion and sustainment of VA-HOP following discontinuation of active implementation support (for 9-months after high intensity support ends) using quantitative implementation outcomes and post-implementation qualitative interviews (Aim 4).
Anticipated Impact: This study will provide information on the relative impacts and relative costs of strategies aimed at implementing a peer-led, stigma reduction intervention for justice-involved Veterans with co-occurring SUD and MH disorders. The findings will provide guidance to VA and other healthcare systems that serve justice-involved Veterans with co-occurring disorders.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前：David A Smelson, PsyD
- 電話番号：(781) 687-7778
- メール：david.smelson@va.gov
研究連絡先のバックアップ
- 名前：Michael A Andre, MPH
- 電話番号：(781) 382-5554
- メール：michael.andre2@va.gov
研究場所
-
-
Massachusetts
-
Bedford、Massachusetts、アメリカ、01730-1114
- 募集
- VA Bedford HealthCare System, Bedford, MA
-
主任研究者：
- David A. Smelson, PsyD
-
コンタクト：
- David A Smelson, PsyD
- 電話番号：(781) 687-7778
- メール：david.smelson@va.gov
-
コンタクト：
- Michael A Andre, MPH
- 電話番号：(781) 382-5554
- メール：michael.andre2@va.gov
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
Veterans who are service-connected and enrolled in a VJP program within six VA Medical Centers:
- Fresno, Palo Alto, Butler, Coatesville, Pittsburgh, Wilmington, and therefore have justice involvement
- Veterans who meet DSM-5 criteria for a mental health and/or substance use disorder
- Veterans who are willing to participate in VA-HOP
Exclusion Criteria:
- Does not have a history of justice involvement and or not enrolled in a participating site VJP program
- Do not have a mental health and/or substance use disorder diagnosis
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：他の
- 割り当て：非ランダム化
- 介入モデル：順次割り当て
- マスキング：なし（オープンラベル）
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ：Low Intensity
Audit and Feedback will be our low intensity implementation strategy.
Peer specialists and key stakeholders will receive monthly data reports on VA-HOP delivery (e.g.
number of sessions delivered, number of Veterans served) and fidelity data with written feedback.
Peers will have the opportunity to join an optional, monthly virtual session to discuss their report with a quantitative expert.
|
VA-HOP is an evidence-based, peer-delivered group intervention designed to help individuals navigate decisions about disclosure of behavioral health conditions.
The intervention consists of three lessons comprising nine structured tasks that guide participants through decisions of disclosure aimed at reducing self-stigma.
The goal of HOP is not to force disclosure; rather, it empowers participants to decide whether, when, and how disclosure may occur.
VA-HOP is facilitated by a peer specialist with a group of 8-10 participants, and sessions can be broken down into a 45-minute weekly session for 9 weeks or 3 weekly 2 1/4-hour blocks.
The first lesson covers the short- and long-term benefits and risks of disclosure and non-disclosure.
The second lesson addresses the different levels of disclosure, emphasizing that disclosure exists on a continuum and can vary depending on the context and audience.
The third lesson focuses on how to tell one's recovery story.
他の名前：
|
|
実験的：High Intensity
Implementation Facilitation will be our high intensity implementation strategy.
Peer specialists and other key stakeholders will participate in biweekly virtual meetings with an external facilitator.
Facilitation activities serve a range of functions spanning problem-solving, relationship-building, and goal setting and planning.
Activities are selected based on site progress and needs.
|
VA-HOP is an evidence-based, peer-delivered group intervention designed to help individuals navigate decisions about disclosure of behavioral health conditions.
The intervention consists of three lessons comprising nine structured tasks that guide participants through decisions of disclosure aimed at reducing self-stigma.
The goal of HOP is not to force disclosure; rather, it empowers participants to decide whether, when, and how disclosure may occur.
VA-HOP is facilitated by a peer specialist with a group of 8-10 participants, and sessions can be broken down into a 45-minute weekly session for 9 weeks or 3 weekly 2 1/4-hour blocks.
The first lesson covers the short- and long-term benefits and risks of disclosure and non-disclosure.
The second lesson addresses the different levels of disclosure, emphasizing that disclosure exists on a continuum and can vary depending on the context and audience.
The third lesson focuses on how to tell one's recovery story.
他の名前：
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Number of VA-HOP Sessions delivered
時間枠：Measured across each implementation period with each participating site; Audit and Feedback (0-6 months), Implementation Facilitation (7-12 months), and Sustainment (13-21 months)
|
Uptake is the study primary outcome and is defined as the number of VA-HOP sessions delivered to Veterans during each implementation period.
Using EHR data submitted into the VA CDW, uptake statistics will be extracted for each implementation period, i.e.
Audit and Feedback (6-months), Implementation Facilitation (6-months), and Sustainment Phase (9-months).
|
Measured across each implementation period with each participating site; Audit and Feedback (0-6 months), Implementation Facilitation (7-12 months), and Sustainment (13-21 months)
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Dose Fidelity Adherence to HOP Model
時間枠：Measured across each implementation period with each participating site; Audit and Feedback (0-6 months), Implementation Facilitation (7-12 months), and Sustainment (13-21 months)
|
Dose Fidelity will be a secondary outcome.
Dose fidelity is defined as a proportion of expected VA-HOP encounters completed by each Veteran.
Fidelity will be assessed from standard documentation embedded within each participating sites EHR completed by VA HOP peer facilitators.
This data will be extracted for each implementation period, i.e.
Audit and Feedback (6-months), Implementation Facilitation (6-months), and Sustainment Phase (9-months).
|
Measured across each implementation period with each participating site; Audit and Feedback (0-6 months), Implementation Facilitation (7-12 months), and Sustainment (13-21 months)
|
|
Content Fidelity Adherence to HOP Model
時間枠：Measured across each implementation period with each participating site; Audit and Feedback (0-6 months), Implementation Facilitation (7-12 months), and Sustainment (13-21 months)
|
Content Fidelity will be a secondary outcome.
Content fidelity is defined as the extent to which peer facilitators complete the three VA-HOP lessons and nine VA-HOP tasks.
Content fidelity will be assessed from standard documentation embedded within each participating sites EHR completed by VA HOP peer facilitators.
This documentation note tracks each VA-HOP Peer facilitator and their use of the VA-HOP lessons and associated tasks.
This data will be extracted for each implementation period, i.e.
Audit and Feedback (6-months), Implementation Facilitation (6-months), and Sustainment Phase (9-months).
|
Measured across each implementation period with each participating site; Audit and Feedback (0-6 months), Implementation Facilitation (7-12 months), and Sustainment (13-21 months)
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Effectiveness-Mental Health Outpatient Care encounters
時間枠：Measured across each implementation period with each participating site; Audit and Feedback (0-6 months), Implementation Facilitation (7-12 months), and Sustainment (13-21 months)
|
Among Veterans who receive VA-HOP, the number of outpatient mental health treatment encounters they have in each implementation phase will be compared.
These data will be collected using VA administrative data.
|
Measured across each implementation period with each participating site; Audit and Feedback (0-6 months), Implementation Facilitation (7-12 months), and Sustainment (13-21 months)
|
|
Effectiveness-Substance Use Disorder Outpatient Care encounters
時間枠：Measured across each implementation period with each participating site; Audit and Feedback (0-6 months), Implementation Facilitation (7-12 months), and Sustainment (13-21 months)
|
Among Veterans who receive VA-HOP, the number of outpatient substance use treatment encounters they have in each implementation phase will be compared.
These data will be collected using VA administrative data.
|
Measured across each implementation period with each participating site; Audit and Feedback (0-6 months), Implementation Facilitation (7-12 months), and Sustainment (13-21 months)
|
|
Effectiveness-Emergency Department Hospitalizations
時間枠：Measured across each implementation period with each participating site; Audit and Feedback (0-6 months), Implementation Facilitation (7-12 months), and Sustainment (13-21 months)
|
Among Veterans who receive VA-HOP, the number of emergency department visits they have in each implementation phase will be compared.
These data will be collected using VA administrative data.
|
Measured across each implementation period with each participating site; Audit and Feedback (0-6 months), Implementation Facilitation (7-12 months), and Sustainment (13-21 months)
|
|
Effectiveness-Suicide Prevention Coordinator Visits
時間枠：Measured across each implementation period with each participating site; Audit and Feedback (0-6 months), Implementation Facilitation (7-12 months), and Sustainment (13-21 months)
|
Among Veterans who receive VA-HOP, Suicide risk measured as the number of engagements with the Suicide Prevention Coordinator they have in each implementation phase will be compared.
These data will be collected using VA administrative data.
|
Measured across each implementation period with each participating site; Audit and Feedback (0-6 months), Implementation Facilitation (7-12 months), and Sustainment (13-21 months)
|
協力者と研究者
捜査官
- 主任研究者：David A. Smelson, PsyD、VA Bedford HealthCare System, Bedford, MA
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- QUX 26-005
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
米国で製造され、米国から輸出された製品。
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。